Related Experiment Video
Updated: Mar 31, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
Published on: June 10, 2020
Kaempferol inhibits Chlamydia psittaci proliferation by blocking lipid transport and RB-EB differentiation
Yinhui Lin1,2, Yufei Jiang2, Shan Zhang2
1Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
Abstract:
Chlamydia psittaci is an obligate intracellular pathogen that poses a significant threat to both human and animal health. The current therapeutic strategies are limited by the emergence of potential drug resistance, underscoring the urgent need for novel anti-chlamydial agents. In this study, we evaluated the anti-chlamydial activity of kaempferol, a natural occurring flavonoid. Potential targets of kaempferol and C. psittaci infection-related targets were identified through in silico screening. In cellular assays using both HeLa and THP-1 cells, kaempferol treatment significantly inhibits the intracellular growth of C. psittaci in a dose-dependent manner, while showing no host cell cytotoxicity at effective concentrations. Based on prior in silico virtual screening and our group's systematic evaluation of the anti-chlamydial activity of flavonoids, kaempferol (40 μM) was selected as the target compound for this study due to its potent antimicrobial effects and its potential to modulate key host-pathogen interaction pathways. Mechanistic investigations revealed that kaempferol interferes with the trafficking of host-derived lipid to the bacterial inclusion, thereby depriving the pathogen of essential nutrients. Moreover, kaempferol treatment severely disrupted the normal differentiation of reticulate bodies (RBs) into infectious elementary bodies (EBs), resulting in an aberrant developmental cycle and a reduction in the production of new infectious progeny. This study demonstrates that kaempferol exerts anti-chlamydial activity by targeting two key processes of C. psittaci infection: lipid trafficking to inclusions and RB-EB conversion. These results highlight kaempferol as a promising lead compound for developing new therapeutic approaches against C. psittaci infections.
Insights
Kaempferol, a natural flavonoid, effectively inhibits Chlamydia psittaci growth by disrupting nutrient supply and developmental cycles. This discovery offers a promising new avenue for treating infections caused by this pathogen.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Chlamydia psittaci is a significant pathogen threatening human and animal health.
- Existing treatments face challenges due to emerging drug resistance.
- Novel anti-chlamydial agents are urgently needed.
Purpose of the Study:
- To evaluate the anti-chlamydial activity of kaempferol, a natural flavonoid.
- To identify potential targets of kaempferol against C. psittaci.
- To explore kaempferol's mechanism of action in inhibiting C. psittaci growth.
Main Methods:
- In silico screening to identify potential targets.
- Cellular assays using HeLa and THP-1 cells to assess anti-chlamydial activity.
- Mechanistic investigations into kaempferol's effects on host-pathogen interactions.
Main Results:
- Kaempferol significantly inhibited intracellular C. psittaci growth in a dose-dependent manner.
- Kaempferol demonstrated no cytotoxicity to host cells at effective concentrations.
- Kaempferol disrupted host lipid trafficking to the bacterial inclusion and inhibited reticulate body to elementary body conversion.
Conclusions:
- Kaempferol exhibits potent anti-chlamydial activity against C. psittaci.
- Kaempferol acts by targeting essential pathogen processes: lipid acquisition and developmental cycle progression.
- Kaempferol represents a promising lead compound for developing new therapeutics against C. psittaci infections.
Related Concept Videos
Bacterial Phylum Chlamydiae
Inhibitors of Gram-positive Cell Wall Synthesis
Antifungal Agents
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
GPCRs Regulate Adenylyl Cylase Activity

